Onconic Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,075,064	869,777	176,537	-	-	-
Market Cap Growth	546.99%	392.69%	-	-	-	-
Enterprise Value	1,022,454	816,363	152,373	-	-	-
Last Close Price	23950.00	19550.00	4085.00	-	-	-
PE Ratio	68.11	55.11	-	-	-	-
PS Ratio	20.14	16.29	11.90	-	-	-
PB Ratio	14.92	12.07	3.15	-	-	-
P/TBV Ratio	14.92	12.07	3.15	-	-	-
P/FCF Ratio	96.92	78.41	-	-	-	-
P/OCF Ratio	94.34	76.33	-	-	-	-
EV/Sales Ratio	19.15	15.29	10.27	-	-	-
EV/EBITDA Ratio	77.77	62.09	-	-	-	-
EV/EBIT Ratio	81.02	64.69	-	-	-	-
EV/FCF Ratio	92.18	73.60	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	-0.72	0.00	-0.02
Debt / EBITDA Ratio	0.01	0.01	-	5.26	-	-
Debt / FCF Ratio	0.01	0.01	-	4.74	-	-
Net Debt / Equity Ratio	-0.73	-0.73	-0.76	0.81	1.24	2.34
Net Debt / EBITDA Ratio	-4.00	-4.00	9.82	-6.28	1.85	2.25
Net Debt / FCF Ratio	-4.74	-4.74	5.35	-5.34	1.56	2.11
Asset Turnover	0.78	0.78	0.30	0.62	0.00	-
Quick Ratio	17.48	17.48	10.61	0.54	1.06	36.08
Current Ratio	17.62	17.62	10.94	0.54	1.06	36.10
Return on Equity (ROE)	24.65%	24.65%	-44.55%	-	-	-
Return on Assets (ROA)	11.55%	11.55%	-6.09%	4.07%	-36.85%	-
Return on Capital Employed (ROCE)	17.50%	17.50%	-8.50%	-11.50%	-343.70%	-44.10%
Earnings Yield	1.47%	1.81%	-4.58%	-	-	-
FCF Yield	1.03%	1.27%	-4.52%	-	-	-
Buyback Yield / Dilution	-	-	-41.46%	0.00%	-0.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.